FIGURE 4.
Current biomarkers under investigation for IO agents. Longitudinal analyses of serial blood, tumour and microbiome samples may provide further insight into tumour dynamics under the treatment selection pressure of immunotherapy
Current biomarkers under investigation for IO agents. Longitudinal analyses of serial blood, tumour and microbiome samples may provide further insight into tumour dynamics under the treatment selection pressure of immunotherapy